SANDOVAL DAVID I. enters MAXCYTE, INC. with 42K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/4/2024ACC: 0000905148-24-000859
Officer· General Counsel
Since Feb 2024
42K
Baseline shares
100% direct
42K
Direct ownership
1 position
72K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned42K
Total
42K direct42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 42K | Direct |
| Total | 42K | 42K direct |
Derivative Holdings1
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
72K
Shares owned
N/A
Exercise price
5.02
Expiration
—
Exercise window
—
Total
Underlying
72K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 5.02 | — | — | 72K | N/A |
| Total | 72K | 0.00 | ||||